$WTW

WTW Investments and SEI announced an expansion of their partnership to develop private markets solutions for U.S. defined contribution plans, including 401(k)s. WTW will provide investment research and portfolio implementation, while SEI will use SEI Trust Company (STC) for trustee, operational, and administrative services for CITs. The goal is broader return diversification for plan sponsors and participants.

Willis Towers Watson (WTW) reported Q2 2026 results on an earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). It outlined Propel, targeting $400 million run-rate savings by 2028 and enterprise margin of about 30%, plus $450 million Q2 buybacks.

Simply Wall St reports Willis Towers Watson (WTW) expanded its partnership with SEI Investments to develop private markets solutions for US defined contribution plans. The article cites a larger buyback authorization and WTW quarterly results, noting 17.52% 30-day and 73.60% 3-year returns. A valuation narrative sets fair value at $358.21 versus $338.07, about 5.6% undervalued, but flags AI and regulatory risks.

Willis Towers Watson (WTW) reported Q2 2026 results on its earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). The company targets $400m run-rate savings by 2028 from a ~$625m AI investment and $360m free cash flow in the first half of 2026.

Willis Towers Watson (WTW) shares rose about 1.5% after Q2 results beat expectations and prompted analyst target increases. According to the company, adjusted EPS was $3.35 vs $3.13 consensus, revenue about $2.47B vs $2.41B, with 5% organic growth. Goldman raised its target to $385 and UBS to $405 (both Buy), while Citigroup downgraded to Neutral with a $345 target.

Willis Towers Watson (WTW) reported Q2 2026 sales of $2,466m and net income of $229m. The company expanded its equity buyback authorization to $13.65bn after $450m of Q2 repurchases, and advanced its Propel AI efficiency program and exposure management leadership hiring. Investors are focused on potential margin gains and capital returns.

Truist Financial analyst Mark Hughes reiterated a Buy on Willis Towers Watson (WTW) with a $400 price target. TipRanks says Hughes is a top analyst. WTW also saw Buy ratings from Mizuho, while Barclays kept a Hold. WTW reported Q2 revenue of $2.47B and net profit of $229M, versus $2.26B and $331M a year earlier.

Willis Towers Watson (WTW) disclosed technology and AI transformation risks, including execution and operational disruption, correlated error, compliance, IP, cyber and resilience risks, and workforce impacts such as role restructuring and potential retention issues. It says governance may not fully mitigate risks and that outcomes could affect revenue growth and competitiveness. Wall Street has a Moderate Buy consensus based on 12 Buys and 5 Holds.

Willis Towers Watson (WTW) discussed its Q2 earnings call, including the Propel program, with most costs expected in 2027-2028 and benefits contributing meaningfully in 2027 through 2028. WTW targeted ~30% adjusted operating margin at the enterprise level in 2028 and reiterated 2026 guidance. Segment organic growth: Health, Wealth & Career +4%, Risk & Broking +7%. WTW repurchased $450M shares and paid $90M dividends in Q2.

Four of the world's biggest insurance brokers reported second-quarter results within nine days of each other this month, which makes for a rare like-for-like comparison. WTW and Arthur J. Gallagher both reported on 30 July, Aon the day before, and Marsh McLennan about a week earlier. On the broking side specifically, WTW came out ahead of all three. WTW's Risk & Broking segment grew organic revenue by 7% in the quarter. Gallagher's Brokerage segment, the most directly comparable unit, grew 5%.